Filtros de búsqueda

Lista de obras de Reinhard Dummer

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

artículo científico publicado en 2016

A DNA replication-independent function of pre-replication complex genes during cell invasion in C. elegans

artículo científico publicado en 2022

A Fatty Acid Oxidation-dependent Metabolic Shift Regulates the Adaptation of BRAF-mutated Melanoma to MAPK Inhibitors

artículo científico publicado en 2019

A Longitudinal Analysis of IDO and PDL1 Expression during Immune- or Targeted Therapy in Advanced Melanoma

artículo científico publicado en 2018

A Monocentric, Retrospective Analysis of 61 Patients with Generalized Granuloma Annulare

scientific article published on 13 May 2020

A Phase I/III, multicenter, open-label trial of talimogene laherparepvec (T-VEC) in combination with pembrolizumab for the treatment of unresected, stage IIIb-IV melanoma (MASTERKEY-265).

artículo científico publicado en 2015

A Prospective Trial Comparing Q-Switched Ruby Laser and a Triple Combination Skin-Lightening Cream in the Treatment of Solar Lentigines

artículo científico publicado en 2016

A Transcriptionally Inactive ATF2 Variant Drives Melanomagenesis.

artículo científico publicado en 2016

A first-in-human phase I, multicenter, open-label, dose-escalation study of the oral RAF/VEGFR-2 inhibitor (RAF265) in locally advanced or metastatic melanoma independent from BRAF mutation status

artículo científico publicado en 2017

A new live-cell biobank workflow efficiently recovers heterogeneous melanoma cells from native biopsies.

artículo científico publicado en 2015

A paracrine activin A-mDia2 axis promotes squamous carcinogenesis via fibroblast reprogramming

artículo científico publicado en 2020

A phase 1b/2 study of the BRAF inhibitor encorafenib plus the MEK inhibitor binimetinib in patients with BRAF V600E/K-mutant solid tumors

scientific article published on 15 July 2020

A phase I, multicenter, open-label, first-in-human, dose-escalation study of the oral smoothened inhibitor Sonidegib (LDE225) in patients with advanced solid tumors

artículo científico publicado en 2014

A phase II study of the L19IL2 immunocytokine in combination with dacarbazine in advanced metastatic melanoma patients

scientific article published on 03 September 2019

A positive FGFR3/FOXN1 feedback loop underlies benign skin keratosis versus squamous cell carcinoma formation in humans

artículo científico publicado en 2009

A positive FGFR3/FOXN1 feedback loop underlies benign skin keratosis versus squamous cell carcinoma formation in humans.

artículo científico publicado en 2010

A practical guide to the handling and administration of talimogene laherparepvec in Europe

artículo científico publicado en 2017

A randomized controlled comparison of pembrolizumab and chemotherapy in patients with ipilimumab-refractory melanoma.

artículo científico publicado en 2015

A review of binimetinib for the treatment of mutant cutaneous melanoma

artículo científico

About moles, melanomas, and lasers: the dermatologist's schizophrenic attitude toward pigmented lesions

artículo científico publicado en 2003

Achievements and challenges of molecular targeted therapy in melanoma

artículo científico publicado en 2015

Activation of CD8+ T cells contributes to anti-tumor effects of CDK4/6 inhibitors plus MEK inhibitors

artículo científico publicado en 2020

Activin enhances skin tumourigenesis and malignant progression by inducing a pro-tumourigenic immune cell response

artículo científico publicado en 2011

Activin promotes skin carcinogenesis by attraction and reprogramming of macrophages.

artículo científico publicado en 2017

Adenovirus-mediated intralesional interferon-gamma gene transfer induces tumor regressions in cutaneous lymphomas

artículo científico publicado en 2004

Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma.

artículo científico publicado en 2017

Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAFV600-mutant, stage III melanoma (COMBI-AD): exploratory biomarker analyses from a randomised, phase 3 trial

artículo científico publicado en 2020

Adjuvant ipilimumab versus placebo after complete resection of stage III melanoma: long-term follow-up results of the European Organisation for Research and Treatment of Cancer 18071 double-blind phase 3 randomised trial

scientific article published on 07 August 2019

Adjuvant melanoma therapy with new drugs: should physicians continue to focus on metastatic disease or use it earlier in primary melanoma?

scientific article published on 01 December 2018

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial ⬇️

artículo científico publicado en 2021

Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial

artículo científico publicado en 2008

Adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma: a phase III randomized controlled trial of health-related quality of life and symptoms by the European Organisation for Research and Treatment of C

artículo científico publicado en 2009

Adverse events 2.0-Let us get SERIOs: New reporting for adverse event outcomes needed in the era of immunooncology

scientific article published on 21 March 2019

Adverse events associated with encorafenib plus binimetinib in the COLUMBUS study: incidence, course and management

scientific article published on 19 August 2019

Aggressive Rare T-cell Lymphomas with Manifestation in the Skin: A Monocentric Cross-sectional Case Study.

artículo científico publicado en 2018

Aldara activates TLR7-independent immune defence

artículo científico publicado en 2013

An Aggressive Hypoxia Related Subpopulation of Melanoma Cells is TRP-2 Negative.

artículo científico publicado en 2014

Analysis of BRAF and NRAS Mutation Status in Advanced Melanoma Patients Treated with Anti-CTLA-4 Antibodies: Association with Overall Survival?

artículo científico publicado en 2015

Analysis of adenovirus trans-complementation-mediated gene expression controlled by melanoma-specific TETP promoter in vitro ⬇️

artículo científico publicado el 29 de julio de 2010

Angioimmunoblastic T-Cell Lymphoma Mimicking Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS Syndrome)

artículo científico publicado en 2017

Antagonistic cross-regulation between Sox9 and Sox10 controls an anti-tumorigenic program in melanoma.

artículo científico publicado en 2015

Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients

scholarly article by Mirjam Fässler et al published 20 February 2019 in Journal for Immunotherapy of Cancer

Assessment of quality of life using Skindex-16 in patients with advanced basal cell carcinoma treated with vismodegib in the STEVIE study

scientific article published on 01 December 2018

Association of BRAF V600E/K Mutation Status and Prior BRAF/MEK Inhibition With Pembrolizumab Outcomes in Advanced Melanoma: Pooled Analysis of 3 Clinical Trials

artículo científico publicado en 2020

Atypical melanocytic proliferations and new primary melanomas in patients with advanced melanoma undergoing selective BRAF inhibition

artículo científico publicado en 2012

Basal cell carcinoma: a paradigm for targeted therapies

artículo científico

Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab

artículo científico publicado en 2016

Baseline staging of melanoma with unknown primary site: the value of serum s100 protein and positron emission tomography

artículo científico publicado en 2008

Benefit of the nivolumab and ipilimumab combination in pretreated advanced melanoma.

artículo científico publicado en 2018

Binimetinib in heavily pretreated patients with NRAS-mutant melanoma with brain metastases

scientific article published on 09 October 2019

Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial.

artículo científico publicado en 2017

Biomarker results from a phase II study of MEK1/2 inhibitor binimetinib (MEK162) in patients with advanced - or -mutated melanoma

Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation

artículo científico publicado en 2020

Brentuximab as a Treatment for CD30+Mycosis Fungoides and Sézary Syndrome

article

Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial

artículo científico publicado en 2017

CMET-26. DIAGNOSTIC VALUE OF FDG-PET/CT FOR PATIENTS WITH BRAIN METASTASIS FROM UNKNOWN PRIMARY SITE

COT drives resistance to RAF inhibition through MAP kinase pathway reactivation

artículo científico publicado en 2010

Cancer-retina antigens as potential paraneoplastic antigens in melanoma-associated retinopathy

artículo científico publicado en 2009

Cancer-testis antigens and immunosurveillance in human cutaneous squamous cell and basal cell carcinomas.

artículo científico publicado en 2010

Cancer/testis antigen MAGE-A4 expression pattern differs in epithelial skin tumors of organ-transplant recipients and immunocompetent patients.

artículo científico publicado en 2007

Case Report: Encephalitis, with Brainstem Involvement, Following Checkpoint Inhibitor Therapy in Metastatic Melanoma

artículo científico publicado en 2017

Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial

artículo científico publicado en 2021

Characterization and Management of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell Carcinoma.

scientific article published on 10 August 2016

Characterization of the DNA copy-number genome in the blood of cutaneous T-cell lymphoma patients

artículo científico publicado en 2011

Characterizing CD44 regulatory microRNAs as putative therapeutic agents in human melanoma

artículo científico publicado en 2019

Chemotherapy response assessment in stage IV melanoma patients-comparison of 18F-FDG-PET/CT, CT, brain MRI, and tumormarker S-100B.

artículo científico publicado en 2008

Clinical diversity and treatment approaches to blastic plasmacytoid dendritic cell neoplasm: a retrospective multicentre study

artículo científico publicado en 2020

Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of

artículo científico publicado en 2011

Clinical experience with combination BRAF/MEK inhibitors for melanoma with brain metastases: a real-life multicenter study

artículo científico publicado en 2019

Clinical experience: practical management of five patients with cutaneous T-cell lymphoma (CTCL)-related symptoms

artículo científico publicado en 2006

Clinical implications of distinct metastasizing preferences of different melanoma subtypes

scientific article published on 01 March 2014

Clinical observation of panniculitis in two patients with BRAF-mutated metastatic melanoma treated with a combination of a BRAF inhibitor and a MEK inhibitor

artículo científico publicado en 2015

Clinical phase I intratumoral administration of two recombinant ALVAC canarypox viruses expressing human granulocyte-macrophage colony-stimulating factor or interleukin-2: the transgene determines the composition of the inflammatory infiltrate

article

Co-existence of BRAF and NRAS driver mutations in the same melanoma cells results in heterogeneity of targeted therapy resistance.

artículo científico publicado en 2016

Combinations of Toll-like receptor 8 agonist TL8-506 activate human tumor-derived dendritic cells

artículo científico publicado en 2022

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

artículo científico publicado en 2015

Combined PD-1, BRAF and MEK inhibition in advanced BRAF-mutant melanoma: safety run-in and biomarker cohorts of COMBI-i

artículo científico publicado en 2020

Combined treatment with pegylated interferon-alpha-2a and dacarbazine in patients with advanced metastatic melanoma: a phase 2 study

artículo científico publicado en 2008

Combining talimogene laherparepvec with immunotherapies in melanoma and other solid tumors

artículo científico publicado en 2017

Comment on 'Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines'

scientific article published on 30 March 2020

Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, o

article

Complement is a central mediator of radiotherapy-induced tumor-specific immunity and clinical response

artículo científico publicado en 2015

Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma.

artículo científico publicado en 2017

Consistent expression of the stem cell renewal factor BMI-1 in primary and metastatic melanoma

artículo científico publicado en 2007

Constitutional intraepidermal ascent of melanocytes: a potential pitfall in the diagnosis of melanocytic lesions

artículo científico publicado en 2012

Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score

artículo científico publicado en 2020

Correction: In Vivo E2F Reporting Reveals Efficacious Schedules of MEK1/2-CDK4/6 Targeting and mTOR-S6 Resistance Mechanisms

scientific article published on 01 December 2018

Correction: RASopathic Skin Eruptions during Vemurafenib Therapy.

artículo científico publicado en 2013

Correction: Tusup et al. Evaluation of the Interplay between the ADAR Editome and Immunotherapy in Melanoma. Non-Coding RNA 2021, 7, 5

artículo científico publicado en 2022

Critical aspects to achieve a high-quality melanoma clinic.

artículo científico publicado en 2016

Curing advanced melanoma by 2025.

artículo científico publicado en 2015

Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type, With Bilateral Intraocular Involvement and Infiltration to the CNS.

artículo científico publicado en 2014

Cutaneous drug eruptions associated with the use of new oncological drugs.

artículo científico publicado en 2012

Cutaneous lymphomas: molecular pathways leading to new drugs

artículo científico

Cutaneous melanoma: uncommon presentations

artículo científico publicado en 2005

Cutaneous squamous cell carcinomas on special locations: perioral, periocular and genital area

scientific article published on 01 December 2019

Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy

artículo científico publicado en 2016

Cytokine Release Syndrome During Sequential Treatment With Immune Checkpoint Inhibitors and Kinase Inhibitors for Metastatic Melanoma

artículo científico publicado en 2019

Cytokine release syndrome as an important differential diagnosis of severe skin toxicity with organ damage during switch from immunotherapy to targeted therapy in metastatic melanoma

artículo científico publicado en 2019

Cytotoxic Cutaneous Adverse Drug Reactions during Anti-PD-1 Therapy.

artículo científico publicado en 2016

Dapsone in a Large Tertiary Center: Outdated Therapeutic Option or Timeless Agent?

artículo científico publicado en 2019

Data mining The Cancer Genome Atlas in the era of precision cancer medicine

artículo científico publicado en 2015

Dedifferentiated melanomas: Morpho-phenotypic profile, genetic reprogramming and clinical implications

artículo científico publicado en 2020

Definition of anti-tyrosinase MAb T311 linear determinant by proteome-based similarity analysis

scientific article published on 01 July 2005

Detection of melanoma relapse: first comparative analysis on imaging techniques versus S100 protein.

artículo científico publicado en 2006

Development of encorafenib for BRAF-mutated advanced melanoma

artículo científico publicado en 2018

Diagnosis and treatment of Kaposi's sarcoma: European consensus-based interdisciplinary guideline (EDF/EADO/EORTC)

artículo científico publicado en 2019

Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines

scientific article published on 06 July 2019

Different patterns of fibronectin and tenascin-C splice variants expression in primary and metastatic melanoma lesions.

artículo científico publicado en 2011

Differential Diagnosis of Melanocytic Lesions and Molecular Biology ⬇️

artículo científico publicado el 1 de febrero de 2011

Differential LEF1 and TCF4 expression is involved in melanoma cell phenotype switching

artículo científico publicado en 2011

Diffuse Cutaneous Melanosis Associated with Malignant Melanoma.

artículo científico publicado en 2015

Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment.

artículo científico publicado en 2005

Disseminated Primary Cutaneous CD8+ Small/Medium-sized Pleomorphic T-cell Lymphoma Responding to Hydroxychloroquine

artículo científico publicado en 2015

Distinct Clinicopathological and Prognostic Features of Thin Nodular Primary Melanomas: An International Study from 17 Centers

artículo científico publicado en 2019

Does the distribution pattern of brain metastases during BRAF inhibitor therapy reflect phenotype switching?

artículo científico publicado en 2017

Downregulation of the Ubiquitin Ligase RNF125 Underlies Resistance of Melanoma Cells to BRAF Inhibitors via JAK1 Deregulation.

artículo científico publicado en 2015

Dual role of the antioxidant enzyme peroxiredoxin 6 in skin carcinogenesis

artículo científico publicado en 2013

EGFR signalling as a negative regulator of Notch1 gene transcription and function in proliferating keratinocytes and cancer

artículo científico publicado en 2008

EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome.

artículo científico publicado en 2006

EZH2-Mediated Primary Cilium Deconstruction Drives Metastatic Melanoma Formation

scientific article published on 28 June 2018

Efficacy and Safety of APO866 in Patients With Refractory or Relapsed Cutaneous T-Cell Lymphoma: A Phase 2 Clinical Trial

artículo científico publicado en 2016

Efficacy and Safety of Sonidegib in Adult Patients with Nevoid Basal Cell Carcinoma Syndrome (Gorlin Syndrome): Results from a Phase 2, Double-Blind, Randomized Trial

artículo científico publicado en 2020

Efficacy and safety of colchicine in inflammatory skin diseases: a retrospective, monocentric study in a large tertiary center

scientific article published on 20 November 2019

Efficacy of sonidegib in histologic subtypes of advanced basal cell carcinoma: Results from the final analysis of the randomized phase 2 Basal Cell Carcinoma Outcomes With LDE225 Treatment (BOLT) trial at 42 months

artículo científico publicado en 2020

Eighth American Joint Committee on Cancer (AJCC) melanoma classification: Let us reconsider stage III.

artículo científico publicado en 2017

Elastosis colloidalis conglomerata (adult colloid milium, paracolloid of the skin): a maximal manifestation of actinic elastosis?

artículo científico publicado en 2006

Electrical Impedance Spectroscopy in Skin Cancer Diagnosis.

artículo científico publicado en 2017

Emerging drugs and combination strategies for basal cell carcinoma

artículo científico

Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial.

artículo científico publicado en 2018

Engineering melanoma progression in a humanized environment in vivo.

artículo científico publicado en 2011

Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study

artículo científico publicado en 2019

Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4

artículo científico publicado en 2021

Establishment of a mouse xenograft model for mycosis fungoides

artículo científico publicado en 2004

European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies

artículo científico

European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2017.

artículo científico publicado en 2017

European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas

artículo científico publicado en 2008

Evaluation of clinicopathological factors in PD-1 response: derivation and validation of a prediction scale for response to PD-1 monotherapy

artículo científico publicado en 2017

Evaluation of lymphangiogenic markers in Sézary syndrome ⬇️

artículo científico publicado el 17 de septiembre de 2010

Evaluation of the National Swiss Skin Cancer Screening Campaign 2013: Do We Do the Right Thing

artículo científico publicado en 2017

Evaluation of the minimal erythema dose for UVB and UVA in context of skin phototype and nature of photodermatosis

scientific article published on 06 February 2020

Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma

artículo científico publicado en 2007

Evidence and interdisciplinary consensus-based German guidelines: surgical treatment and radiotherapy of melanoma

artículo científico publicado en 2008

Evolving impact of long-term survival results on metastatic melanoma treatment

artículo científico publicado en 2020

Excimer laser versus narrow-band UVB (311 nm) in the treatment of psoriasis vulgaris

artículo científico publicado en 2006

Expanded access programmes: patient interests versus clinical trial integrity

artículo científico publicado en 2014

Expression of CD164 on Malignant T cells in Sézary Syndrome

article

Expression of Glioma-associated oncogene homolog 1 as biomarker with sonidegib in advanced basal cell carcinoma

scientific article published on 15 September 2020

Expression of MAGE-C1/CT7 and MAGE-C2/CT10 predicts lymph node metastasis in melanoma patients

artículo científico publicado en 2011

Expression of Melan-A/MART-1 in primary melanoma cell cultures has prognostic implication in metastatic melanoma patients

artículo científico publicado en 2004

Expression of melanoma-associated antigens in melanoma cell cultures

artículo científico publicado en 2005

Extracutaneous transformation into a high-grade lymphoma: a potential pitfall in the management of patients with Sézary syndrome

artículo científico publicado en 2006

Facial blaschkitis: case and review.

scientific article published on 27 May 2011

Fas Ligand Reduces Viability in Primary Melanoma Short-Term Cell Cultures More than in Metastatic Melanoma Short-Term Cell Cultures

artículo científico publicado en 2005

Final analysis of a randomised trial comparing pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory advanced melanoma.

artículo científico publicado en 2017

Fine analysis of spontaneous MAGE-C1/CT7-specific immunity in melanoma patients

artículo científico publicado en 2010

Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma

scientific article published on 02 September 2020

Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

artículo científico publicado en 2019

Five-year outcomes from a phase 3 METRIC study in patients with BRAF V600 E/K-mutant advanced or metastatic melanoma.

artículo científico publicado en 2019

Flare-Up of Rheumatoid Arthritis by Anti-CTLA-4 Antibody but Not by Anti-PD1 Therapy in a Patient with Metastatic Melanoma.

artículo científico publicado en 2017

Functional expression of the eotaxin receptor CCR3 in CD30+ cutaneous T-cell lymphoma

artículo científico publicado en 2002

Future perspectives in melanoma research "Melanoma Bridge", Napoli, November 30th-3rd December 2016. ⬇️

artículo científico publicado en 2017

Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.

artículo científico publicado en 2016

Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014.

artículo científico publicado en 2015

Genomic correlates of response to CTLA-4 blockade in metastatic melanoma

artículo científico publicado en 2015

Granulomatous Mycosis Fungoides and Granulomatous Slack Skin

article

Green tea extract reduces induction of p53 and apoptosis in UVB-irradiated human skin independent of transcriptional controls

artículo científico publicado en 2008

Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5 mice

artículo científico publicado en 2019

HER3 is a determinant for poor prognosis in melanoma

artículo científico publicado en 2008

HLA-A*26 Is Correlated With Response to Nivolumab in Japanese Melanoma Patients.

artículo científico publicado en 2017

HLA-G in skin cancer: a wolf in sheep's clothing? ⬇️

artículo científico publicado el 1 de noviembre de 2003

Hair Depigmentation and Hair Loss in Advanced Melanoma Treated with Combined Immunotherapy and Targeted Therapy

scientific article published on 07 January 2020

Health-related quality of life in the randomised KEYNOTE-002 study of pembrolizumab versus chemotherapy in patients with ipilimumab-refractory melanoma

artículo científico publicado en 2016

Health-related quality of life results from the phase III CheckMate 067 study.

artículo científico publicado en 2017

Health-related quality of life with adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): secondary outcomes of a multinational, randomised, double-blind, phase 3 trial

artículo científico publicado en 2017

Hedgehog pathway inhibitors promote adaptive immune responses in basal cell carcinoma.

artículo científico publicado en 2015

Hedgehog signaling in basal cell carcinoma.

artículo científico

High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy

artículo científico publicado en 2018

High-risk melanoma: accuracy of FDG PET/CT with added CT morphologic information for detection of metastases.

artículo científico publicado en 2007

High-throughput mutation profiling of CTCL samples reveals KRAS and NRAS mutations sensitizing tumors toward inhibition of the RAS/RAF/MEK signaling cascade.

scientific article published on 05 January 2011

High-throughput oncogene mutation profiling in human cancer

article

Histological evaluation of a "residual" metastasis after ipilimumab therapy in a patient with advanced melanoma

artículo científico publicado en 2015

How I treat metastatic melanoma

scientific article published on 21 July 2019

How melanoma is treated in real life

artículo científico publicado en 2008

Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth

artículo científico publicado en 2011

Human Melanoma-Associated Mast Cells Display a Distinct Transcriptional Signature Characterized by an Upregulation of the Complement Component 3 That Correlates With Poor Prognosis

artículo científico publicado en 2022

Human leukocyte antigen-G and cancer immunoediting

artículo científico publicado en 2008

Hypoxia contributes to melanoma heterogeneity by triggering HIF1α-dependent phenotype switching

artículo científico publicado en 2013

Id2 suppression of p15 counters TGF-beta-mediated growth inhibition of melanoma cells

artículo científico publicado en 2009

Identification of miR-200a-5p targeting the peptide transporter TAP1 and its association with the clinical outcome of melanoma patients

scientific article published on 03 June 2020

Identification of microRNAs Targeting the Transporter Associated with Antigen Processing TAP1 in Melanoma

artículo científico publicado en 2020

Identification of monoclonal anti-HMW-MAA antibody linear peptide epitope by proteomic database mining

artículo científico publicado en 2004

Immunoglobulin G and Subclasses as Potential Biomarkers in Metastatic Melanoma Patients Starting Checkpoint Inhibitor Treatment

artículo científico publicado en 2019

Immunological effects of BRAF+MEK inhibition

artículo científico publicado en 2018

Immunoscreening of a cutaneous T-cell lymphoma library for plasma membrane proteins

artículo científico publicado en 2006

Immunotherapy of metastatic melanoma by intratumoral injections of Vero cells producing human IL-2: phase II randomized study comparing two dose levels

artículo científico publicado en 2002

Improved overall survival in melanoma with combined dabrafenib and trametinib

artículo científico publicado en 2015

Improved survival with MEK inhibition in BRAF-mutated melanoma

artículo científico publicado en 2012

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

artículo científico publicado en 2011

In Vivo E2F Reporting Reveals Efficacious Schedules of MEK1/2-CDK4/6 Targeting and mTOR-S6 Resistance Mechanisms.

artículo científico publicado en 2018

In vivo profiling reveals immunomodulatory effects of sorafenib and dacarbazine on melanoma

artículo científico publicado en 2015

Induction of genes mediating interferon-dependent extracellular trap formation during neutrophil differentiation

artículo científico publicado en 2004

Ingenol Mebutate Signals via PKC/MEK/ERK in Keratinocytes and Induces Interleukin Decoy Receptors IL1R2 and IL13RA2.

artículo científico publicado en 2015

Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma Therapy

artículo científico publicado en 2016

Inhibition of Age-Related Therapy Resistance in Melanoma by Rosiglitazone-Mediated Induction of Klotho.

artículo científico publicado en 2017

Innovative Therapeutic Approaches in Primary Cutaneous B Cell Lymphoma

artículo científico publicado en 2020

Integrating first-line treatment options into clinical practice: what's new in advanced melanoma?

artículo científico

Integrative analysis of the melanoma transcriptome

artículo científico publicado en 2010

Intense pulsed light

artículo científico publicado en 2011

Interleukin-2 primes eosinophil degranulation in hypereosinophilia and Wells' syndrome

artículo científico publicado en 2003

Internet based health promotion campaign against skin cancer - Results of www.skincheck.ch in Switzerland

artículo científico publicado en 2009

Interstitial granulomatous dermatitis during talimogen laherparepvec treatment

artículo científico publicado en 2017

Intra-lesional low-dose interferon alpha2a therapy for primary cutaneous marginal zone B-cell lymphoma

artículo científico publicado en 2006

Intralesional adenovirus-mediated interleukin-2 gene transfer for advanced solid cancers and melanoma

artículo científico publicado en 2008

Intratumoral injection of DNA encoding human interleukin 12 into patients with metastatic melanoma: clinical efficacy

scientific article published on 01 January 2005

Investigative drugs for the treatment of cutaneous T-cell lymphomas (CTCL): an update

scientific article published on 18 August 2019

Ipilimumab and early signs of pulmonary toxicity in patients with metastastic melanoma: a prospective observational study

artículo científico publicado en 2017

Is single versus combination therapy problematic in the treatment of cutaneous melanoma?

scientific article published on 19 March 2020

Keratinocytic Malfunction as a Trigger for the Development of Solar Lentigines

article

Laser Treatment of Accidental Tattoos: Experience at a Tertiary Referral Center

scientific article published on 02 April 2020

Laser treatment of solar lentigines on dorsum of hands: QS Ruby laser versus ablative CO2 fractional laser - a randomized controlled trial

artículo científico publicado en 2015

Less can be more: the impact of chemotherapy on cutaneous T-cell lymphomas

artículo científico publicado en 2013

Light-based therapies and scar sarcoidosis

artículo científico publicado en 2020

Liver Metastasis and Treatment Outcome with Anti-PD-1 Monoclonal Antibody in Patients with Melanoma and NSCLC.

artículo científico publicado en 2017

Long term follow up of the EORTC 18952 trial of adjuvant therapy in resected stage IIB-III cutaneous melanoma patients comparing intermediate doses of interferon-alpha-2b (IFN) with observation: Ulceration of primary is key determinant for IFN-sensi

artículo científico publicado en 2016

Long-Term Disease Control After Allogeneic Hematopoietic Stem Cell Transplantation in Primary Cutaneous T-Cell Lymphoma; Results From a Single Institution Analysis

artículo científico publicado en 2020

Long-Term Response to Intermittent Binimetinib in Patients with NRAS-Mutant Melanoma

artículo científico publicado en 2020

Long-term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42-month analysis of the phase II randomized, double-blind BOLT study

artículo científico publicado en 2019

Long-term pegylated interferon-alpha and its potential in the treatment of melanoma

artículo científico publicado en 2009

Long-term recurrence rate of large and difficult to treat cutaneous squamous cell carcinomas after superficial radiotherapy

artículo científico publicado en 2012

Long-term results of the randomized phase III trial EORTC 18991 of adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma

artículo científico publicado en 2012

Long-term safety of pembrolizumab monotherapy and relationship with clinical outcome: A landmark analysis in patients with advanced melanoma

artículo científico publicado en 2020

Loss of YY1, a Regulator of Metabolism in Melanoma, Drives Melanoma Cell Invasiveness and Metastasis Formation

artículo científico publicado en 2022

MEK inhibition and immune responses in advanced melanoma.

artículo científico publicado en 2017

MEK inhibition may increase survival of NRAS-mutated melanoma patients treated with checkpoint blockade: Results of a retrospective multicentre analysis of 364 patients

artículo científico publicado en 2018

MEK1 mutations confer resistance to MEK and B-RAF inhibition

artículo científico publicado en 2009

MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study

artículo científico publicado en 2013

Management of pegylated interferon alpha toxicity in adjuvant therapy of melanoma

artículo científico publicado en 2012

Maximal surgical tumour load reduction in immune-checkpoint inhibitor naïve patients with melanoma brain metastases correlates with prolonged survival

artículo científico publicado en 2022

Mechanisms underlying imiquimod-induced regression of basal cell carcinoma in vivo

artículo científico publicado en 2003

Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth

artículo científico publicado en 2015

Melanoma after laser therapy of pigmented lesions--circumstances and outcome

artículo científico publicado en 2010

Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015

artículo científico publicado en 2016

Melanoma immunotherapy: historical precedents, recent successes and future prospects.

artículo científico publicado en 2013

Melanoma occurring during treatment with fingolimod for multiple sclerosis: a case report

artículo científico publicado en 2011

Melanoma patients with additional primary cancers: a single-center retrospective analysis.

artículo científico publicado en 2019

Melanoma's next top model, it is in the air.

artículo científico publicado en 2015

Memory and effector CD8 T-cell responses after nanoparticle vaccination of melanoma patients

artículo científico publicado en 2010

Metastatic acral lentiginous melanoma in a tertiary referral center in Switzerland: a systematic analysis

artículo científico publicado en 2018

Metastatic basal cell carcinoma: prognosis dependent on anatomic site and spread of disease

artículo científico publicado en 2014

Metastatic melanoma cell lines do not secrete IL-1β but promote IL-1β production from macrophages.

artículo científico publicado en 2014

Metastatic melanoma moves on: translational science in the era of personalized medicine.

artículo científico publicado en 2017

Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature

artículo científico publicado en 2006

Methadone-Not a magic bullet in melanoma therapy

scientific article published on 01 June 2018

Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma

artículo científico publicado en 2015

Mitogen-activated protein/extracellular signal-regulated kinase kinase inhibition results in biphasic alteration of epidermal homeostasis with keratinocytic apoptosis and pigmentation disorders.

artículo científico publicado en 2010

Modeling genomic diversity and tumor dependency in malignant melanoma

artículo científico publicado en 2008

Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance

artículo científico publicado en 2013

Molecularly targeted therapy for melanoma: current reality and future options

artículo científico publicado en 2006

Morpho-Molecular Assessment Indicates New Prognostic Aspects and Personalized Therapeutic Options in Sinonasal Melanoma

artículo científico publicado en 2019

Multicenter study of pegylated liposomal doxorubicin in patients with cutaneous T-cell lymphoma

artículo científico publicado en 2003

Multicenter, real-life experience with checkpoint inhibitors and targeted therapy agents in advanced melanoma patients in Switzerland

artículo científico publicado en 2017

Multifocal epithelial tumors and field cancerization from loss of mesenchymal CSL signaling

artículo científico publicado en 2012

Mycosis fungoides--analysis of the duration of disease stages in patients who progress and the time point of high-grade transformation

artículo científico publicado en 2007

NGS-pipe: a flexible, easily extendable, and highly configurable framework for NGS analysis.

artículo científico publicado en 2017

NRASQ61K melanoma tumor formation is reduced by p38-MAPK14 activation in zebrafish models and NRAS-mutated human melanoma cells

scientific article published on 10 September 2020

Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8⁺ T-cell responses in melanoma patients

artículo científico publicado en 2012

Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy

artículo científico publicado en 2016

Nevoid Basal Cell Carcinoma Syndrome: Report from the Zurich Nevoid Basal Cell Carcinoma Syndrome Cohort

artículo científico publicado en 2016

New and experimental skin-directed therapies for cutaneous lymphomas

artículo científico publicado en 2009

New diagnostic method for lesions with transepidermal melanocytic migration.

artículo científico publicado en 2014

Nivolumab for Patients With Advanced Melanoma Treated Beyond Progression: Analysis of 2 Phase 3 Clinical Trials

artículo científico publicado en 2017

Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial

artículo científico publicado en 2018

Non-self-discrimination as a driving concept in the identification of an immunodominant HMW-MAA epitopic peptide sequence by autoantibodies from melanoma cancer patients

artículo científico publicado en 2004

Noncutaneous Melanomas: A Single-Center Analysis.

artículo científico publicado en 2015

Novel MITF targets identified using a two-step DNA microarray strategy

artículo científico publicado en 2008

Nrf2 Activation Promotes Keratinocyte Survival during Early Skin Carcinogenesis via Metabolic Alterations.

artículo científico publicado en 2015

Oligonucleotide array-CGH identifies genomic subgroups and prognostic markers for tumor stage mycosis fungoides

artículo científico publicado en 2009

Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy

artículo científico publicado en 2018

Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy.

artículo científico publicado en 2017

Oncolytic measles virus in cutaneous T-cell lymphomas mounts antitumor immune responses in vivo and targets interferon-resistant tumor cells

artículo científico publicado en 2005

Osteoblasts contribute to a protective niche that supports melanoma cell proliferation and survival

scientific article published on 08 August 2019

Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.

artículo científico publicado en 2017

Overall survival in patients with BRAF-mutant melanoma receiving encorafenib plus binimetinib versus vemurafenib or encorafenib (COLUMBUS): a multicentre, open-label, randomised, phase 3 trial

artículo científico publicado en 2018

Overall survival of patients with chemotherapy-naive advanced melanoma treated with ipilimumab 3 mg/kg in clinical trials.

artículo científico publicado en 2014

PARP1 inhibitor olaparib (Lynparza) exerts synthetic lethal effect against ligase 4-deficient melanomas.

artículo científico publicado en 2016

PI3K Pathway Inhibition Achieves Potent Antitumor Activity in Melanoma Brain Metastases In Vitro and In Vivo

artículo científico publicado en 2016

PI3K signalling is required for a TGFβ-induced epithelial-mesenchymal-like transition (EMT-like) in human melanoma cells

artículo científico publicado en 2014

PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma

artículo científico publicado en 2013

Panniculitis after subcutaneous injection of interferon beta in a multiple sclerosis patient

artículo científico publicado en 2002

Panobinostat activity in both bexarotene-exposed and -naïve patients with refractory cutaneous T-cell lymphoma: results of a phase II trial

artículo científico publicado en 2012

Pathogenesis and therapy of cutaneous lymphomas--progress or impasse?

artículo científico publicado en 2006

Patient-reported outcomes in patients with resected, high-risk melanoma with BRAFV600E or BRAFV600K mutations treated with adjuvant dabrafenib plus trametinib (COMBI-AD): a randomised, placebo-controlled, phase 3 trial

scientific article published on 27 March 2019

Patient-reported quality of life in patients with relapsed/refractory cutaneous T-cell lymphoma: Results from the randomised phase III ALCANZA study

artículo científico publicado en 2020

Patterns of care and follow-up care of patients with uveal melanoma in German-speaking countries: a multinational survey of the German Dermatologic Cooperative Oncology Group (DeCOG)

scientific article published on 21 November 2020

Patterns of onset and resolution of immune-related adverse events of special interest with ipilimumab: detailed safety analysis from a phase 3 trial in patients with advanced melanoma

artículo científico publicado en 2013

Pegylated liposomal doxorubicin-associated hand-foot syndrome: recommendations of an international panel of experts

artículo científico publicado en 2008

Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial

artículo científico publicado en 2015

Pembrolizumab-triggered Uveitis: An Additional Surrogate Marker for Responders in Melanoma Immunotherapy?

artículo científico publicado en 2016

Perspectives in melanoma: Meeting report from the Melanoma Bridge (30 November-2 December, 2017, Naples, Italy)

artículo científico publicado en 2018

Perspectives in melanoma: meeting report from the "Melanoma Bridge" (December 5th-7th, 2019, Naples, Italy)

artículo científico publicado en 2020

Perspectives in melanoma: meeting report from the Melanoma Bridge (November 29th-1 December 1st, 2018, Naples, Italy)

artículo científico publicado en 2019

Perturbing resistance: a network perspective.

artículo científico publicado en 2016

Phase I Dose-Escalation and -Expansion Study of the BRAF Inhibitor Encorafenib (LGX818) in Metastatic BRAF-Mutant Melanoma

artículo científico publicado en 2017

Phase I, open-label study of pasireotide in patients with BRAF-wild type and NRAS-wild type, unresectable and/or metastatic melanoma

scientific article published on 23 July 2018

Phase II clinical trial of intratumoral application of TG1042 (adenovirus-interferon-gamma) in patients with advanced cutaneous T-cell lymphomas and multilesional cutaneous B-cell lymphomas

artículo científico publicado en 2010

Phase II, open-label, randomized trial of the MEK1/2 inhibitor selumetinib as monotherapy versus temozolomide in patients with advanced melanoma

artículo científico publicado en 2011

Phototherapy with UVB narrowband, UVA/UVBnb, and UVA1 differentially impacts serum 25-hydroxyvitamin-D3.

artículo científico publicado en 2013

Potassium Iodide for Cutaneous Inflammatory Disorders: A Monocentric, Retrospective Study

artículo científico publicado en 2018

Practical clinical guide on the use of talimogene laherparepvec monotherapy in patients with unresectable melanoma in Europe

scientific article published on 01 December 2018

Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score

artículo científico publicado en 2020

Predictive value of the MGMT promoter methylation status in metastatic melanoma patients receiving first-line temozolomide plus bevacizumab in the trial SAKK 50/07

artículo científico publicado en 2012

Primary cutaneous CD30+ anaplastic large-cell lymphomas show a heterogeneous genomic profile: an oligonucleotide arrayCGH approach

artículo científico publicado en 2010

Primary cutaneous follicle center lymphoma with diffuse CD30 expression: a report of 4 cases of a rare variant.

artículo científico publicado en 2014

Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement.

artículo científico publicado en 2006

Primary localization and tumor thickness as prognostic factors of survival in patients with mucosal melanoma.

artículo científico publicado en 2014

Progression of cutaneous squamous cell carcinoma in immunosuppressed patients is associated with reduced CD123+ and FOXP3+ cells in the perineoplastic inflammatory infiltrate.

artículo científico publicado en 2009

Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy

artículo científico publicado en 2016

Prospective international multicenter phase II trial of intravenous pegylated liposomal doxorubicin monochemotherapy in patients with stage IIB, IVA, or IVB advanced mycosis fungoides: final results from EORTC 21012.

artículo científico publicado en 2012

Proteomic identification of a marker signature for MAPKi resistance in melanoma

scientific article published on 26 June 2019

Proteomics-based insights into mitogen-activated protein kinase inhibitor resistance of cerebral melanoma metastases.

artículo científico publicado en 2018

Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors.

artículo científico publicado en 2004

Publisher Correction: The low affinity neurotrophin receptor CD271 regulates phenotype switching in melanoma

artículo científico publicado en 2018

Pyogenic granuloma in patients treated with selective BRAF inhibitors: another manifestation of paradoxical pathway activation.

artículo científico publicado en 2016

RASopathic skin eruptions during vemurafenib therapy

artículo científico publicado en 2013

Radiomics, tumor volume and blood biomarkers for early prediction of pseudoprogression in metastatic melanoma patients treated with immune checkpoint inhibition

artículo científico publicado en 2020

Radiotherapy in Periocular Cutaneous Malignancies: A Retrospective Study

artículo científico publicado en 2019

Rapidly Evolving Extensive Fluorodeoxyglucose-Positive Soft-Tissue Activity During Nivolumab Therapy

scientific article published on 01 May 2019

Rationale for Immune Checkpoint Inhibitors Plus Targeted Therapy in Metastatic Melanoma: A Review

artículo científico publicado en 2020

Real-life experience with pegylated interferon and conventional interferon in adjuvant melanoma therapy

artículo científico publicado en 2013

Real-world approach to actinic keratosis management: practical treatment algorithm for office-based dermatology.

artículo científico publicado en 2016

Recent advances in cutaneous lymphomas

artículo científico publicado en 2007

Recent advances in primary cutaneous T-cell lymphoma

artículo científico publicado en 2015

Recombinant measles virus induces cytolysis of cutaneous T-cell lymphoma in vitro and in vivo

artículo científico publicado en 2006

Recurrent squamous cell carcinoma of the perianal skin: a case report

artículo científico publicado en 2020

Regulatory T Cells Restrain Pathogenic T Helper Cells during Skin Inflammation

artículo científico publicado en 2018

Reply to E. Hindié and K.R. Hess

artículo científico publicado en 2019

Resistance patterns with tyrosine kinase inhibitors in melanoma: new insights

artículo científico

Response assessment and outcome of combining immunotherapy and radiosurgery for brain metastasis from malignant melanoma

artículo científico publicado en 2020

Response to: Comment on 'Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines'

scientific article published on 22 September 2020

Retrospective Analysis of Treatment and Complications of Immune Checkpoint Inhibitor-Associated Colitis: Histological Ulcerations as Potential Predictor for a Steroid-Refractory Disease Course

scientific article published on 26 May 2020

Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment

artículo científico publicado en 2007

Role of imiquimod in skin cancer treatment

artículo científico publicado en 2004

Romidepsin and Azacitidine Synergize in their Epigenetic Modulatory Effects to Induce Apoptosis in CTCL.

artículo científico publicado en 2015

SMAD signaling promotes melanoma metastasis independently of phenotype switching

artículo científico publicado en 2019

SOX10 ablation arrests cell cycle, induces senescence, and suppresses melanomagenesis

artículo científico publicado en 2013

SPANX control of Lamin A/C modulates nuclear architecture and promotes melanoma growth

artículo científico publicado en 2020

Safety and efficacy of nivolumab in challenging subgroups with advanced melanoma who progressed on or after ipilimumab treatment: A single-arm, open-label, phase II study (CheckMate 172)

scientific article published on 30 September 2019

Safety and efficacy of nivolumab in patients with rare melanoma subtypes who progressed on or after ipilimumab treatment: a single-arm, open-label, phase II study (CheckMate 172)

scientific article published on 21 August 2019

Safety and efficacy of vemurafenib in BRAF(V600E) and BRAF(V600K) mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study

artículo científico publicado en 2014

Sarcoid-like reactions in patients receiving modern melanoma treatment.

artículo científico publicado en 2018

Selumetinib plus dacarbazine versus placebo plus dacarbazine as first-line treatment for BRAF-mutant metastatic melanoma: a phase 2 double-blind randomised study

artículo científico publicado en 2013

Senescent fibroblast-derived Chemerin promotes squamous cell carcinoma migration

artículo científico publicado en 2016

Sequential somatic mutations upon secondary anti-HER2 treatment resistance in metastatic ERBB2S310F mutated extramammary Paget's disease

artículo científico publicado en 2019

Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy

scientific article published on 01 December 2020

Serum S100B Levels in Melanoma

scientific article published on 01 January 2019

Severe acute respiratory distress syndrome due to ipilimumab

artículo científico publicado en 2013

Short German guidelines: malignant melanoma

artículo científico publicado en 2008

Single-center real-life experience with low-dose ipilimumab monotherapy in adjuvant setting for patients with stage III melanoma

artículo científico publicado en 2019

Sinonasal, genital and acrolentiginous melanomas show distinct characteristics of KIT expression and mutations.

artículo científico publicado en 2012

Skin problems associated with pegylated liposomal doxorubicin-more than palmoplantar erythrodysesthesia syndrome.

artículo científico publicado en 2008

Sonidegib and vismodegib in the treatment of patients with locally advanced basal cell carcinoma: a joint expert opinion

scientific article published on 28 January 2020

Sonidegib for the treatment of advanced basal cell carcinoma

artículo científico publicado en 2016

Sorafenib in melanoma

artículo científico

Special considerations for stage IV melanoma during pregnancy

scientific article published on 01 September 2005

Spindle-cell variant of primary cutaneous follicle center lymphoma spreading to the hepatobiliary tree, mimicking Klatskin tumor

artículo científico publicado en 2012

Spitzoid melanoma and micrometastases in two lymph node regions: a critical situation

artículo científico publicado en 2011

Spontaneous CD8 T cell responses against the melanocyte differentiation antigen RAB38/NY-MEL-1 in melanoma patients

artículo científico publicado en 2006

Standard and experimental therapy in cutaneous T-cell lymphomas

artículo científico publicado en 2006

Stevens-Johnson syndrome and toxic epidermal necrolysis overlap in a patient receiving cetuximab and radiotherapy for head and neck cancer

artículo científico publicado en 2012

Successful Use of Grenz Rays for Disseminated Superficial Actinic Porokeratosis: Report of 8 Cases

artículo científico publicado en 2017

Successful treatment of multiple keratoacanthoma with topical imiquimod and low-dose acitretin

artículo científico publicado en 2011

Successful treatment with imatinib after nilotinib and ipilimumab in a c-kit-mutated advanced melanoma patient: a case report

artículo científico publicado en 2017

Sustained androgen receptor signaling is a determinant of melanoma cell growth potential and tumorigenesis

artículo científico publicado en 2021

Symplastic glomus tumor - a rare but distinct benign histological variant with analogy to other 'ancient' benign skin neoplasms

artículo científico publicado en 2009

Systematic classification of melanoma cells by phenotype-specific gene expression mapping.

artículo científico publicado en 2012

TG1042 (Adenovirus-interferon-γ) in primary cutaneous B-cell lymphomas: a phase II clinical trial

artículo científico publicado en 2014

TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of

scientific article published on 05 March 2007

Targeted therapy in melanoma - the role of BRAF, RAS and KIT mutations

artículo científico

Targeted treatment of advanced NRAS-mutated melanoma

artículo científico publicado en 2017

Targeting PHGDH upregulation reduces glutathione levels and re-sensitizes resistant NRAS mutant melanoma to MEK inhibition

artículo científico publicado en 2020

Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failure

artículo científico publicado en 2017

Targeting hyperactivation of the AKT survival pathway to overcome therapy resistance of melanoma brain metastases

scientific article published on 03 February 2013

Targeting the MAPK and PI3K pathways in combination with PD1 blockade in melanoma.

artículo científico publicado en 2016

Temozolomide in combination with interferon-alfa versus temozolomide alone in patients with advanced metastatic melanoma: a randomized, phase III, multicenter study from the Dermatologic Cooperative Oncology Group

artículo científico publicado en 2005

Temporal activation of WNT/β-catenin signaling is sufficient to inhibit SOX10 expression and block melanoma growth

scientific article published on 01 April 2020

The 12-month analysis from Basal Cell Carcinoma Outcomes with LDE225 Treatment (BOLT): A phase II, randomized, double-blind study of sonidegib in patients with advanced basal cell carcinoma

artículo científico publicado en 2016

The 2017 complete overhaul of adjuvant therapies for high-risk melanoma and its consequences for staging and management of melanoma patients

artículo científico publicado en 2017

The Genetic Evolution of Melanoma from Precursor Lesions

artículo científico publicado en 2015

The World of Melanoma: Epidemiologic, Genetic, and Anatomic Differences of Melanoma Across the Globe

scientific article published on 24 September 2018

The association between immune checkpoint or BRAF/MEK inhibitor therapy and uveitis in patients with advanced cutaneous melanoma

artículo científico publicado en 2020

The concepts of rechallenge and retreatment in melanoma: A proposal for consensus definitions

scientific article published on 26 August 2020

The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors.

artículo científico publicado en 2015

The immunohistochemistry of invasive and proliferative phenotype switching in melanoma: a case report

artículo científico publicado en 2010

The price of tumor control: an analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab network

artículo científico publicado en 2013

The role of Cyclin D1 and Ki-67 in the development and prognostication of thin melanoma

scientific article published on 06 May 2020

The safety of anti PD-1 therapeutics for the treatment of melanoma

artículo científico publicado en 2016

The spectrum of widespread hyperpigmentations from SLN to SUL

artículo científico publicado en 2009

The state of melanoma: challenges and opportunities

artículo científico publicado en 2016

The updated Swiss guidelines 2016 for the treatment and follow-up of cutaneous melanoma

artículo científico publicado en 2016

The use of anti-T-cell receptor-Vbeta antibodies for the estimation of treatment success and phenotypic characterization of clonal T-cell populations in cutaneous T-cell lymphomas

artículo científico publicado en 2002

Toward Minimal Residual Disease-Directed Therapy in Melanoma

scientific article published on 12 July 2018

Toxicity of combined targeted therapy and concurrent radiotherapy in metastatic melanoma patients: a single-center retrospective analysis

artículo científico publicado en 2020

Treatment algorithms in stage IV melanoma

artículo científico

Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial.

artículo científico

Tumor cell plasticity and angiogenesis in human melanomas

artículo científico publicado en 2012

Tumour assessment in advanced melanoma: value of FDG-PET/CT in patients with elevated serum S-100B.

artículo científico publicado en 2007

Tumour hypoxia promotes melanoma growth and metastasis via High Mobility Group Box-1 and M2-like macrophages

artículo científico publicado en 2016

Ulceration and stage are predictive of interferon efficacy in melanoma: results of the phase III adjuvant trials EORTC 18952 and EORTC 18991.

artículo científico publicado en 2011

Ultraviolet A and photosensitivity during vemurafenib therapy

artículo científico publicado en 2012

Unexpected contribution of lymphatic vessels to promotion of distant metastatic tumor spread

artículo científico publicado en 2018

Update on tolerability and overall survival in COLUMBUS: landmark analysis of a randomised phase 3 trial of encorafenib plus binimetinib vs vemurafenib or encorafenib in patients with BRAF V600-mutant melanoma

scientific article published on 02 January 2020

Upstream mitogen-activated protein kinase (MAPK) pathway inhibition: MEK inhibitor followed by a BRAF inhibitor in advanced melanoma patients

artículo científico publicado en 2013

Use of Lasers for Iron-Induced Accidental Tattoos: Experience at a Tertiary Referral Center

artículo científico publicado en 2019

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

scientific article published on 01 March 1998

Vemurafenib in patients with BRAF(V600) mutation-positive melanoma with symptomatic brain metastases: final results of an open-label pilot study

artículo científico publicado en 2013

Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial

artículo científico publicado en 2015

Vitamin D, ultraviolet exposure, and skin cancer in the elderly

artículo científico publicado en 2010

Voodoo medicine still going strong: a tale of melanoma, faith, and failure

artículo científico publicado en 2008

Vorinostat combined with bexarotene for treatment of cutaneous T-cell lymphoma: in vitro and phase I clinical evidence supporting augmentation of retinoic acid receptor/retinoid X receptor activation by histone deacetylase inhibition

artículo científico publicado en 2012

Weight of decision-making impairs clinical assessment of melanocytic lesions.

artículo científico publicado en 2007

Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets

scientific article published on 18 July 2019

Yin Yang 1 Orchestrates a Metabolic Program Required for Both Neural Crest Development and Melanoma Formation

scientific article published on 01 April 2019

[Brief guidelines: malignant melanoma of the skin]

artículo científico publicado en 2006

[Current therapy of carcinoma of the skin]

scientific article published on 01 September 2010

[Perspective of cutaneous lymphoma reserach].

artículo científico publicado en 2006

low neurotrophin receptor CD271 regulates phenotype switching in melanoma

artículo científico publicado en 2017

mTORC1/autophagy-regulated MerTK in mutant BRAFV600 melanoma with acquired resistance to BRAF inhibition

artículo científico publicado en 2017

p16 expression in primary malignant melanoma is associated with prognosis and lymph node status

artículo científico publicado en 2006

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda